Icon

RYTHMOL SR (nda021416)- (225MG,325MG,425MG)

PROPAFENONE HYDROCHLORIDE GLAXOSMITHKLINE LLC
225MG,325MG,425MG
Yes No
2014-Oct-28 Expired
None None
None No
RYTHMOL SR is an antiarrhythmic indicated to prolong the time to recurrence of symptomatic atrial fibrillation (AF) in patients with episodic (most likely paroxysmal or persistent) AF who do not have structural heart disease.
9 0 9
Total Other Developers 7
Drugs with Suitability No
225MG ** ** - - 8
325MG ** ** - - 8
425MG ** ** - - 7
NDA Sales Available Total Generic Sales Available
No 8
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ******* ****** ******* ******, *** *********** * *** ***** **, ******** *****, *** **** (**) *****-****, ****** ****** (***) ***
****** ****** **** *** ****** ****** ******* ******* *********** **** **. **-*-*, ***** ** ***** ********** ******, *****, ********, *** ******, ***** (***) ***
****** ******** ****** *** ******** *************** ******* *********** **** **. *, *****-*, ****** **** *** *********, ****, ****** ******* ******, ***** (***) ***
****** ****** *** ******* ******* *********** *-**, **, ***, **, **, **, **, ** & *-**, ****, ******* ****** ***** *****, ******, *****, ***** & *** ******, ***** (***) ***
****** ****** ***** **** ******-***** ************, *** *********** *** * ******** **, ******, ******** (**) *****-****, ****** ****** (***) ***
****** ****** ***** **** ******-***** ************, *** *********** **** ******** ***** *, ***** *****, ********* (**) *****-****, ****** ****** (***) ***
****** *** ****** *** ***************, ***. ******* ***** *********** *-*, ******* *** **., ******* ****, ******, ****** (***) ***
****** ***** ************ ***** ************ ******* *********** **** **. *-*/*&* *******, (******* ******** ****) ******, ******* ***** *.*. **. **, ***-******, ****-*********, *********, ******* ******, ***** (***) ***
****** ********* ****** *** ********* ****** ******* *********** ****-***, ** **. ***/*, ***/*, ***/*, ***/* & ***/*, **** ** **** ***, *****, ***** ********** ****, *********, ********* ******, ************, ********* ******, ***** (***) ***
****** **************** *** ****** ****** ***. *********** **.***, ****** **, ******** ******, ****** ********, *******, ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.